Nutanix, Inc. (NTNX) Q2 2026 Earnings Call February 25, 2026 4:30 PM EST
Company Participants
Richard Valera – Vice President of Investor Relations
Rajiv Ramaswami – CEO & Director
Rukmini Sivaraman – Principal Accounting Officer & CFO
Conference Call Participants
Radi Sultan – UBS Investment Bank, Research Division
James Fish – Piper Sandler & Co., Research Division
Sanjit Singh – Morgan Stanley, Research Division
Ruplu Bhattacharya – BofA Securities, Research Division
Matthew Martino – Goldman Sachs Group, Inc., Research Division
Manmohanpreet Singh – JPMorgan Chase & Co, Research Division
Benjamin Bollin – Cleveland Research Company LLC
Brandon Nispel – KeyBanc Capital Markets Inc., Research Division
Nehal Chokshi – Northland Capital Markets, Research Division
Dan Bergstrom – RBC Capital Markets, Research Division
Michael Cikos – Needham & Company, LLC, Research Division
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Nutanix Q2 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your first speaker today, Rich Valera, Vice President of Investor Relations. Please go ahead.
Richard Valera
Vice President of Investor Relations
Good afternoon, and welcome to today’s conference call to discuss second quarter fiscal year 2026 financial results. Joining me today are Rajiv Ramaswami, Nutanix’ CEO; and Rukmini Sivaraman, Nutanix’ CFO. After the market closed today, Nutanix issued a press release announcing second quarter fiscal year 2026 financial results. If you’d like to read the release, please visit the Press Releases section of our IR website.
During today’s call, management will make forward-looking statements, including financial guidance. These forward-looking statements involve risks and uncertainties, some of which are beyond our control, which could cause actual results to differ materially and adversely from those anticipated by these statements. For a more detailed description of these and other risks and uncertainties, please refer to our SEC filings, including our most
